Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
Document Type
Article
Publication Title
Clinical Case Reports
Abstract
Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti-cancer agents for treatment of Gastric cancers.
DOI
10.1002/ccr3.4986
Publication Date
11-1-2021
Recommended Citation
Limaye, Sewanti; Patil, Darshana; Akolkar, Dadasaheb; and Srivastava, Navin, "Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma" (2021). Open Access archive. 2359.
https://impressions.manipal.edu/open-access-archive/2359
COinS
